Prospective Observation of 5-year Clinical Course of Subclinical Hypothyroidism in Korean Population
Overview
Authors
Affiliations
Subclinical hypothyroidism (SCH) is a common clinical condition, whereas it's natural course has not been identified distinctly. We evaluated the natural history of 169 SCH patients over 5-yr and the prognostic factors including thyroid autoantibodies and thyroid ultrasonographic (USG) findings related to develop overt hypothyroidism. After 5 yr, 47.3% of patients showed normalization of TSH, while 36.7% of patients remained persistence of high level of TSH, and overt hypothyroidism developed in 11.2% of patients. There were painless thyroiditis (2.9%) and hyperthyroidism (1.7%) during 5 yr follow-up. The thyroid nodule was seen in 48.6% of patients. Most of patients had 1 to 2 nodules whereas only 3% of patients with thyroid nodule had more than 6 nodules. Overt hypothyroidism patients had more heterogenous echogenecity in USG compared to patients with normalization or persistent SCH (76.5% vs 50.0% vs 35.0%, P = 0.048) and higher prevalence positive anti-thyroid peroxidase (anti-TPO Ab) and anti-thyroglobulin antibody (anti-Tg Ab) and titer of anti-TPO Ab than other two groups. The cut off values for prediction of overt hypothyroidism were TSH > 7.45 µIU/mL, free T4 < 1.09 ng/dL and Anti-TPO Ab > 560 IU/mL. SCH has various courses and initial TSH, free T4, presence of thyroid autoantibody, titer of thyroid autoantibody; and thyroid USG findings can serve as a prognostic factor for progression of overt hypothyroidism. These parameters suggest consideration to initiate thyroid hormone treatment in SCH.
Zhong F, Guan Q, Zhang H, Zhang X, Zhao M, Yuan Z EClinicalMedicine. 2022; 53:101629.
PMID: 36060516 PMC: 9433604. DOI: 10.1016/j.eclinm.2022.101629.
Amouzegar A, Dehghani M, Abdi H, Mehran L, Masoumi S, Azizi F J Endocrinol Invest. 2022; 45(12):2353-2364.
PMID: 35925467 DOI: 10.1007/s40618-022-01876-6.
Zheng Y, Dong S, Gong Y, Wang J, Wang F, Zeng Q Front Endocrinol (Lausanne). 2022; 13:820414.
PMID: 35242111 PMC: 8887626. DOI: 10.3389/fendo.2022.820414.
A model of functional thyroid disease status over the lifetime.
Dzierlenga M, Allen B, Ward P, Clewell 3rd H, Longnecker M PLoS One. 2019; 14(7):e0219769.
PMID: 31318913 PMC: 6638952. DOI: 10.1371/journal.pone.0219769.